Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Enhanced down-regulation of ALCAM/CD166 in African-American breast cancer

Tan, F and Mosunjac, M and Adams, AL and Adade, B and Taye, O and Hu, Y and Rizzo, M and Ofori-Acquah, SF (2014) Enhanced down-regulation of ALCAM/CD166 in African-American breast cancer. BMC Cancer, 14 (1).

Published Version
Available under License : See the attached license file.

Download (651kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)


Background: Variation in tumor biology in African-American (AA) and Caucasian (CAU) women with breast cancer is poorly defined. Activated leukocyte cell adhesion molecule (ALCAM) is a bad prognostic factor of breast cancer yet it has never being studied in the AA population. We tested the hypothesis that ALCAM expression would be markedly lower in cases of AA breast cancer when compared to CAU. Methods: Cases of breast cancer among AA (n = 78) and CAU (n = 95) women were studied. Immunohistochemical staining was used to semi-quantitatively score ALCAM expression in tumor and adjacent non-tumor breast tissues. Clinico-pathological characteristics including histological type, histological grade, tumor size, lymph node metastasis, estrogen receptor (ER), progesterone receptor (PR), and HER2-neu status were abstracted, and their association with ALCAM expression tested. Results: Univariate analysis revealed that the level of ALCAM expression at intercellular junctions of primary tumors correlates with histological grade (AA; p = 0.04, CUA; p = 0.02), ER status (AA; p = 0.0004, CAU; p = 0.0015), PR status (AA; p = 0.002, CUA p = 0.034) and triple-negative tumor status (AA; p = 0.0002, CAU; p = 0.0006,) in both ethnic groups. Multivariate analysis demonstrated that ethnicity contribute significantly to ALCAM expression after accounting for basal-like subtype, age, histological grade, tumor size, and lymph node status. Compared to CAU tumors, the AA are 4 times more likely to have low ALCAM expression (p = 0.003). Conclusions: Markedly low expression of ALCAM at sites of cell-cell contact in primary breast cancer tumors regardless of differentiation, size and lymph node involvement may contribute to the more aggressive phenotype of breast cancer among AA women.


Social Networking:
Share |


Item Type: Article
Status: Published
CreatorsEmailPitt UsernameORCID
Tan, F
Mosunjac, M
Adams, AL
Adade, B
Taye, O
Hu, Y
Rizzo, M
Ofori-Acquah, SFSFO2@pitt.eduSFO2
Date: 25 September 2014
Date Type: Publication
Journal or Publication Title: BMC Cancer
Volume: 14
Number: 1
DOI or Unique Handle: 10.1186/1471-2407-14-715
Schools and Programs: School of Medicine > Medicine
School of Medicine > Pediatrics
Refereed: Yes
Date Deposited: 19 Sep 2016 16:39
Last Modified: 03 Apr 2021 11:55


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item